. 2015 May 8;3(3):e00141. doi: 10.1002/prp2.141
© 2015 GlaxoSmithKline. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Figure 1.
Structures of N-thiazolylamide and synthetic FFA2 ligands used in this study.